Calcitonin-derived peptide carriers: Mechanisms and application

Advanced Drug Delivery Reviews

Volumn 60, Issue 4-5, 2008, Pages 485-498

  Rennert, Robert ^a   Neundorf, Ines ^a   Beck Sickinger, Annette G ^a  

^a Faculty of Biosciences Pharmacy and Psychology   (Germany)

Author keywords

Cell transfection; Cell penetrating peptides; Cellular delivery; Human calcitonin; Metabolic stability; Uptake mechanism

Indexed keywords

CELL MEMBRANES; DRUG DELIVERY; HORMONES; METABOLISM;

CELL TRANSFECTION; CELL-PENETRATING PEPTIDES; CELLULAR DELIVERY; HUMAN CALCITONIN;

PROTEINS;

CALCITONIN; CALCITONIN DERIVATIVE; DAUNORUBICIN; NUCLEIC ACID;

DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG METABOLISM; DRUG STRUCTURE; DRUG UPTAKE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CALCITONIN; CARRIER PROTEINS; CELL MEMBRANE; DRUG DELIVERY SYSTEMS; HUMANS; MODELS, BIOLOGICAL; PEPTIDES; TECHNOLOGY, PHARMACEUTICAL;

EID: 39149101777     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2007.09.008     Document Type: Review

References (104)

1. Wong T.K., and Neumann E. Electric field mediated gene transfer. Biochem. Biophys. Res. Commun. 107 (1982) 584-587
2. Lee R.J., and Huang L. Lipidic vector systems for gene transfer. Crit. Rev. Ther. Drug Carr. Syst. 14 (1997) 173-206
3. Langer M., Kratz F., Rothen-Rutishauser B., Wunderli-Allenspach H., and Beck-Sickinger A.G. Novel peptide conjugates for tumor-specific chemotherapy. J. Med. Chem. 44 (2001) 1341-1348
4. Brave A., Ljungberg K., Wahren B., and Liu M.A. Vaccine delivery methods using viral vectors. Mol. Pharmacol. 4 (2007) 18-32
5. Derossi D., Joliot A.H., Chassaing G., and Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269 (1994) 10444-10450
6. Vives E., Brodin P., and Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272 (1997) 16010-16017
7. Lemken M.L., Wolf C., Wybranietz W.A., Schmidt U., Smirnow I., Buhring H.J., Mack A.F., Lauer U.M., and Bitzer M. Evidence for intercellular trafficking of VP22 in living cells. Molec. Ther. 15 (2007) 310-319
8. Pooga M., Hallbrink M., Zorko M., and Langel U. Cell penetration by transportan. FASEB J. 12 (1998) 67-77
9. Deshayes S., Morris M.C., Divita G., and Heitz F. Interactions of primary amphipathic cell penetrating peptides with model membranes: consequences on the mechanisms of intracellular delivery of therapeutics. Curr. Pharm. Des. 11 (2005) 3629-3638
10. Oehlke J., Scheller A., Wiesner B., Krause E., Beyermann M., Klauschenz E., Melzig M., and Bienert M. Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim. Biophys. Acta 1414 (1998) 127-139
11. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., and Sugiura Y. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276 (2001) 5836-5840
12. Sheldon K., Liu D., Ferguson J., and Gariepy J. Loligomers: design of de novo peptide-based intracellular vehicles. Proc Natl. Acad. Sci. U. S. A. 92 (1995) 2056-2060
13. Krauss U., Kratz F., and Beck-Sickinger A.G. Novel daunorubicin-carrier peptide conjugates derived from human calcitonin segments. J. Mol. Recognit. 16 (2003) 280-287
14. Machova Z., Muhle C., Krauss U., Trehin R., Koch A., Merkle H.P., and Beck-Sickinger A.G. Cellular internalization of enhanced green fluorescent protein ligated to a human calcitonin-based carrier peptide. Chembiochem 3 (2002) 672-677
15. Copp D.H., Cameron E.C., Cheney B.A., Davidson A.G., and Henze K.G. Evidence for calcitonin - a new hormone from the parathyroid that lowers blood calcium. Endocrinol. 70 (1962) 638-649
16. Nakamuta H., Itokazu Y., Koida M., Orlowski R.C., and Epand R.M. Autoradiographic localization of human calcitonin sensitive binding sites in rat brain. Jpn. J. Pharmacol. 56 (1991) 551-555
17. Purdue B.W., Tilakaratne N., and Sexton P.M. Molecular pharmacology of the calcitonin receptor. Recep. Channels 8 (2002) 243-255
18. Austin L.A., and Heath H. 3rd, Calcitonin: physiology and pathophysiology. New Engl. J. Med. 304 (1981) 269-278
19. Sexton P.M., Findlay D.M., and Martin T.J. Calcitonin. Curr. Med. Chem. 6 (1999) 1067-1093
20. Motta A., Andreotti G., Amodeo P., Strazzullo G., and Castiglione Morelli M.A. Solution structure of human calcitonin in membrane-mimetic environment: the role of the amphipathic helix. Proteins 32 (1998) 314-323
21. Levy F., Muff R., Dotti-Sigrist S., Dambacher M.A., and Fischer J.A. Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of Paget's disease. J. Clin. Endocrinol. Metab. 67 (1988) 541-545
22. Pontiroli A.E., Alberetto M., and Pozza G. Intranasal calcitonin and plasma calcium concentrations in normal subjects. Br. Med. J. (Clin. Res. Ed. 1981) 290 (1985) 1390-1391
23. Pontiroli A.E., Pajetta E., Calderara A., Alberetto M., Pozza G., Manganelli V., Resmini G., Tessari L., and Maresca V. Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget's disease of bones: a pilot study. J. Endocrinol. Invest. 14 (1991) 47-51
24. Silverman S.L. Calcitonin. Endocrinol. Metab. Clin. N. Am. 32 (2003) 273-284
25. Colman E., Hedin R., Swann J., and Orloff D. A brief history of calcitonin. Lancet 359 (2002) 885-886
26. Hirsch P.F., and Baruch H. Is calcitonin an important physiological substance?. Endocrine 21 (2003) 201-208
27. Schmidt M.C., Rothen-Rutishauser B., Rist B., Beck-Sickinger A., Wunderli-Allenspach H., Rubas W., Sadee W., and Merkle H.P. Translocation of human calcitonin in respiratory nasal epithelium is associated with self-assembly in lipid membrane. Biochemistry 37 (1998) 16582-16590
28. Motta A., Temussi P.A., Wunsch E., and Bovermann G. A 1H NMR study of human calcitonin in solution. Biochemistry 30 (1991) 2364-2371
29. Arvinte T., and Drake A.F. Comparative study of human and salmon calcitonin secondary structure in solutions with low dielectric constants. J. Biol. Chem. 268 (1993) 6408-6414
30. Siligardi G., Samori B., Melandri S., Visconti M., and Drake A.F. Correlations between biological activities and conformational properties for human, salmon, eel, porcine calcitonins and Elcatonin elucidated by CD spectroscopy. Eur. J. Biochem. 221 (1994) 1117-1125
31. Amodeo P., Motta A., Strazzullo G., and Castiglione Morelli M.A. Conformational flexibility in calcitonin: the dynamic properties of human and salmon calcitonin in solution. J. Biomol. NMR 13 (1999) 161-174
32. Kazantzis A., Waldner M., Taylor J.W., and Kapurniotu A. Conformationally constrained human calcitonin (hCt) analogues reveal a critical role of sequence 17-21 for the oligomerization state and bioactivity of hCt. Eur. J. Biochem. 269 (2002) 780-791
33. Epand R.M., Epand R.F., Orlowski R.C., Schlueter R.J., Boni L.T., and Hui S.W. Amphipathic helix and its relationship to the interaction of calcitonin with phospholipids. Biochemistry 22 (1983) 5074-5084
34. Trehin R., Krauss U., Muff R., Meinecke M., Beck-Sickinger A.G., and Merkle H.P. Cellular internalization of human calcitonin derived peptides in MDCK monolayers: a comparative study with Tat(47-57) and penetratin(43-58). Pharm. Res. 21 (2004) 33-42
35. Trehin R., and Merkle H.P. Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur. J. Pharm. Biopharm. 58 (2004) 209-223
36. Lundberg M., and Johansson M. Is VP22 nuclear homing an artifact?. Nat. Biotechnol. 19 (2001) 713-714
37. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J., Chernomordik L.V., and Lebleu B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278 (2003) 585-590
38. Lundberg M., and Johansson M. Positively charged DNA-binding proteins cause apparent cell membrane translocation. Biochem. Biophys. Res. Commun. 291 (2002) 367-371
39. Hed J., Hallden G., Johansson S.G., and Larsson P. The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation. J. Immunol. Methods 101 (1987) 119-125
40. Foerg C., Ziegler U., Fernandez-Carneado J., Giralt E., Rennert R., Beck-Sickinger A.G., and Merkle H.P. Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape. Biochemistry 44 (2005) 72-81
41. Rennert R., Wespe C., Beck-Sickinger A.G., and Neundorf I. Developing novel hCT derived cell-penetrating peptides with improved metabolic stability. Biochim. Biophys. Acta 1758 (2006) 347-354
42. Muff R., Born W., and Fischer J.A. Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions. Eur. J. Endocrinol. 133 (1995) 17-20
43. Trehin R., Krauss U., Beck-Sickinger A.G., Merkle H.P., and Nielsen H.M. Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models. Pharm. Res. 21 (2004) 1248-1256
44. Schwarze S.R., Ho A., Vocero-Akbani A., and Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285 (1999) 1569-1572
45. Deshayes S., Morris M.C., Divita G., and Heitz F. Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell. Mol. Life Sci. 62 (2005) 1839-1849
46. Gupta B., Levchenko T.S., and Torchilin V.P. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv. Drug. Deliv. Rev. 57 (2005) 637-651
47. Wiethoff C.M., and Middaugh C.R. Barriers to nonviral gene delivery. J. Pharm. Sci. 92 (2003) 203-217
48. Koppelhus U., Awasthi S.K., Zachar V., Holst H.U., Ebbesen P., and Nielsen P.E. Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates. Antisense Nucleic Acid Drug Dev. 12 (2002) 51-63
49. Herbig M.E., Fromm U., Leuenberger J., Krauss U., Beck-Sickinger A.G., and Merkle H.P. Bilayer interaction and localization of cell penetrating peptides with model membranes: a comparative study of a human calcitonin (hCT)-derived peptide with pVEC and pAntp(43-58). Biochim. Biophys. Acta 1712 (2005) 197-211
50. Herbig M.E., Weller K., Krauss U., Beck-Sickinger A.G., Merkle H.P., and Zerbe O. Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides. Biophys. J. 89 (2005) 4056-4066
51. White S.H., and Wimley W.C. Hydrophobic interactions of peptides with membrane interfaces. Biochim. Biophys. Acta 1376 (1998) 339-352
52. Lundberg P., and Langel U. A brief introduction to cell-penetrating peptides. J. Mol. Recogn. 16 (2003) 227-233
53. Wagner K., Van Mau N., Boichot S., Kajava A.V., Krauss U., Le Grimellec C., Beck-Sickinger A., and Heitz F. Interactions of the human calcitonin fragment 9-32 with phospholipids: a monolayer study. Biophys. J. 87 (2004) 386-395
54. Zasadzinski J.A., Viswanathan R., Madsen L., Garnaes J., and Schwartz D.K. Langmuir-Blodgett films. Science 263 (1994) 1726-1733
55. Brockman H. Lipid monolayers: why use half a membrane to characterize protein-membrane interactions?. Curr. Opin. Struct. Biol. 9 (1999) 438-443
56. Stipani V., Gallucci E., Micelli S., Picciarelli V., and Benz R. Channel formation by salmon and human calcitonin in black lipid membranes. Biophys. J. 81 (2001) 3332-3338
57. Demel R.A., Geurts van Kessel W.S., Zwaal R.F., Roelofsen B., and van Deenen L.L. Relation between various phospholipase actions on human red cell membranes and the interfacial phospholipid pressure in monolayers. Biochim. Biophys. Acta 406 (1975) 97-107
58. Wagner K., Beck-Sickinger A.G., and Huster D. Structural investigations of a human calcitonin-derived carrier peptide in a membrane environment by solid-state NMR. Biochemistry 43 (2004) 12459-12468
59. Russell Y., Evans P., and Dodd G.H. Characterization of the total lipid and fatty acid composition of rat olfactory mucosa. J. Lipid Res. 30 (1989) 877-884
60. Wimley W.C., and White S.H. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat. Struct. Biol. 3 (1996) 842-848
61. Arvinte T., Cudd A., and Drake A.F. The structure and mechanism of formation of human calcitonin fibrils. J. Biol. Chem. 268 (1993) 6415-6422
62. Bauer H.H., Muller M., Goette J., Merkle H.P., and Fringeli U.P. Interfacial adsorption and aggregation associated changes in secondary structure of human calcitonin monitored by ATR-FTIR spectroscopy. Biochemistry 33 (1994) 12276-12282
63. Boichot S., Krauss U., Plenat T., Rennert R., Milhiet P.E., Beck-Sickinger A., and Le Grimellec C. Calcitonin-derived carrier peptide plays a major role in the membrane localization of a peptide-cargo complex. FEBS Lett. 569 (2004) 346-350
64. Fastenberg M.E., Shogomori H., Xu X., Brown D.A., and London E. Exclusion of a transmembrane-type peptide from ordered-lipid domains (rafts) detected by fluorescence quenching: extension of quenching analysis to account for the effects of domain size and domain boundaries. Biochemistry 42 (2003) 12376-12390
65. Polozov I.V., Polozova A.I., Molotkovsky J.G., and Epand R.M. Amphipathic peptide affects the lateral domain organization of lipid bilayers. Biochim. Biophys. Acta 1328 (1997) 125-139
66. van Duyl B.Y., Rijkers D.T., de Kruijff B., and Killian J.A. Influence of hydrophobic mismatch and palmitoylation on the association of transmembrane alpha-helical peptides with detergent-resistant membranes. FEBS Lett. 523 (2002) 79-84
67. Epand R.F., Lehrer R.I., Waring A., Wang W., Maget-Dana R., Lelievre D., and Epand R.M. Direct comparison of membrane interactions of model peptides composed of only Leu and Lys residues. Biopolymers 71 (2003) 2-16
68. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 66 (2002) 236-248
69. Fischer R., Kohler K., Fotin-Mleczek M., and Brock R. A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. J. Biol. Chem. 279 (2004) 12625-12635
70. Xia H., Mao Q., and Davidson B.L. The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors. Nat. Biotechnol. 19 (2001) 640-644
71. Lang S.R., Staudenmann W., James P., Manz H.J., Kessler R., Galli B., Moser H.P., Rummelt A., and Merkle H.P. Proteolysis of human calcitonin in excised bovine nasal mucosa: elucidation of the metabolic pathway by liquid secondary ionization mass spectrometry (LSIMS) and matrix assisted laser desorption ionization mass spectrometry (MALDI). Pharm. Res. 13 (1996) 1679-1685
72. Trehin R., Nielsen H.M., Jahnke H.G., Krauss U., Beck-Sickinger A.G., and Merkle H.P. Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58). Biochem. J. 382 (2004) 945-956
73. Elmquist A., and Langel U. In vitro uptake and stability study of pVEC and its all-D analog. Biol. Chem. 384 (2003) 387-393
74. Powell M.F., Stewart T., Otvos Jr. L., Urge L., Gaeta F.C., Sette A., Arrhenius T., Thomson D., Soda K., and Colon S.M. Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum. Pharm. Res. 10 (1993) 1268-1273
75. Garner P., Sherry B., Moilanen S., and Huang Y. In vitro stability of alpha-helical peptide nucleic acids (alphaPNAs). Bioorg. Med. Chem. Lett. 11 (2001) 2315-2317
76. Simeoni F., Morris M.C., Heitz F., and Divita G. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res. 31 (2003) 2717-2724
77. Gros E., Deshayes S., Morris M.C., Aldrian-Herrada G., Depollier J., Heitz F., and Divita G. A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction. Biochim. Biophys. Acta 1758 (2006) 384-393
78. Munoz-Morris M.A., Heitz F., Divita G., and Morris M.C. The peptide carrier Pep-1 forms biologically efficient nanoparticle complexes. Biochem. Biophys. Res. Commun. 355 (2007) 877-882
79. Weber P.J., Bader J.E., Folkers G., and Beck-Sickinger A.G. A fast and inexpensive method for N-terminal fluorescein-labeling of peptides. Bioorg. Med. Chem. Lett. 8 (1998) 597-600
80. Fischer R., Mader O., Jung G., and Brock R. Extending the applicability of carboxyfluorescein in solid-phase synthesis. Bioconjug. Chem. 14 (2003) 653-660
81. Ayers B., Blaschke U.K., Camarero J.A., Cotton G.J., Holford M., and Muir T.W. Introduction of unnatural amino acids into proteins using expressed protein ligation. Biopolymers 51 (1999) 343-354
82. Xu R., Ayers B., Cowburn D., and Muir T.W. Chemical ligation of folded recombinant proteins: segmental isotopic labeling of domains for NMR studies. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 388-393
83. Dawson P.E., Muir T.W., Clark-Lewis I., and Kent S.B. Synthesis of proteins by native chemical ligation. Science 266 (1994) 776-779
84. Kratz F., Beyer U., and Schutte M.T. Drug-polymer conjugates containing acid-cleavable bonds. Crit. Rev. Ther. Drug. Carr. Syst. 16 (1999) 245-288
85. Mukherjee S., Ghosh R.N., and Maxfield F.R. Endocytosis. Physiol. Rev. 77 (1997) 759-803
86. Langer M., and Beck-Sickinger A.G. Peptides as carrier for tumor diagnosis and treatment. Curr. Med. Chem. Anticancer Agents 1 (2001) 71-93
87. Ragin A.D., Morgan R.A., and Chmielewski J. Cellular import mediated by nuclear localization signal Peptide sequences. Chem. Biol. 9 (2002) 943-948
88. Tung C.H., Mueller S., and Weissleder R. Novel branching membrane translocational peptide as gene delivery vector. Bioorg. Med. Chem. 10 (2002) 3609-3614
89. Futaki S., Nakase I., Suzuki T., Youjun Z., and Sugiura Y. Translocation of branched-chain arginine peptides through cell membranes: flexibility in the spatial disposition of positive charges in membrane-permeable peptides. Biochemistry 41 (2002) 7925-7930
90. Krauss U., Muller M., Stahl M., and Beck-Sickinger A.G. In vitro gene delivery by a novel human calcitonin (hCT)-derived carrier peptide. Bioorg. Med. Chem. Lett. 14 (2004) 51-54
91. Sandgren S., Cheng F., and Belting M. Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide. Role for cell-surface proteoglycans. J. Biol. Chem. 277 (2002) 38877-38883
92. Foerg C., Ziegler U., Fernandez-Carneado J., Giralt E., and Merkle H.P. Differentiation restricted endocytosis of cell penetrating peptides in MDCK cells corresponds with activities of Rho-GTPases. Pharm. Res. 24 (2007) 628-642
93. Hopkins A.M., Walsh S.V., Verkade P., Boquet P., and Nusrat A. Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function. J. Cell Sci. 116 (2003) 725-742
94. Qualmann B., and Mellor H. Regulation of endocytic traffic by Rho GTPases. Biochem. J. 371 (2003) 233-241
95. Jou T.S., Leung S.M., Fung L.M., Ruiz W.G., Nelson W.J., and Apodaca G. Selective alterations in biosynthetic and endocytic protein traffic in Madin-Darby canine kidney epithelial cells expressing mutants of the small GTPase Rac1. Mol. Biol. Cell 11 (2000) 287-304
96. Leung S.M., Rojas R., Maples C., Flynn C., Ruiz W.G., Jou T.S., and Apodaca G. Modulation of endocytic traffic in polarized Madin-Darby canine kidney cells by the small GTPase RhoA. Mol. Biol. Cell 10 (1999) 4369-4384
97. Belting M., Sandgren S., and Wittrup A. Nuclear delivery of macromolecules: barriers and carriers. Adv. Drug Deliv. Rev. 57 (2005) 505-527
98. Luo D., and Saltzman W.M. Synthetic DNA delivery systems. Nat. Biotechnol. 18 (2000) 33-37
99. Thoren P.E., Persson D., Isakson P., Goksor M., Onfelt A., and Norden B. Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem. Biophys. Res. Commun. 307 (2003) 100-107
100. Futaki S. Membrane-permeable arginine-rich peptides and the translocation mechanisms. Adv. Drug Deliv. Rev. 57 (2005) 547-558
101. Cheng J., Zeidan R., Mishra S., Liu A., Pun S.H., Kulkarni R.P., Jensen G.S., Bellocq N.C., and Davis M.E. Structure-function correlation of chloroquine and analogues as transgene expression enhancers in nonviral gene delivery. J. Med. Chem. 49 (2006) 6522-6531
102. Erbacher P., Roche A.C., Monsigny M., and Midoux P. Putative role of chloroquine in gene transfer into a human hepatoma cell line by DNA/lactosylated polylysine complexes. Exp. Cell Res. 225 (1996) 186-194
103. Andreotti G., Mendez B.L., Amodeo P., Morelli M.A., Nakamuta H., and Motta A. Structural determinants of salmon calcitonin bioactivity: the role of the Leu-based amphipathic alpha-helix. J. Biol. Chem. 281 (2006) 24193-24203
104. Hilton J.M., Dowton M., Houssami S., and Sexton P.M. Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors. J. Endocrinol. 166 (2000) 213-226